Stay updated on OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 in the page footer; no impact on study details, locations, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:33:57.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Locations section was reorganized: explicit per-state locations (e.g., California, Colorado, Florida, etc.) were removed and replaced with a general 'Locations' heading listing regions, accompanied by a revision tag update from v3.3.2 to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T08:28:46.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Removed the 'Certification/Extension First Posted' entry from the Study Record Dates. Other date entries, such as First Submitted and Last Update, remain shown.
    Difference
    0.1%
    Check dated 2025-12-08T22:31:03.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision label in the site footer updated from v3.3.1 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-01T16:38:24.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.1; removed the older PubMed-sourced sentence and the Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T11:57:33.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Deleted the government funding/operating status notice that used to appear at the bottom of the page. The notice described potential delays in updates and NIH facility operations.
    Difference
    0.4%
    Check dated 2025-11-17T06:18:43.000Z thumbnail image

Stay in the know with updates to OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.